相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transnasal photoimmunotherapy with cetuximab sarotalocan sodium: Outcomes on the local recurrence of nasopharyngeal squamous cell carcinoma
Go Omura et al.
AURIS NASUS LARYNX (2023)
Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model
Michelle A. Hsu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)
Photoimmunotherapy with surgical navigation and computed tomography guidance for recurrent maxillary sinus carcinoma
Satoshi Koyama et al.
AURIS NASUS LARYNX (2023)
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer
Jung Julie Kang et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
A Case Series on Pain Accompanying Photoimmunotherapy for Head and Neck Cancer
Yuma Shibutani et al.
Healthcare (2023)
Utilization of ultrasound in photoimmunotherapy for head and neck cancer: a case report
Toshihiro Kishikawa et al.
JOURNAL OF ULTRASOUND (2023)
Near-Infrared Photoimmunotherapy for Oropharyngeal Cancer
Daisuke Nishikawa et al.
CANCERS (2022)
Quality-of-Life Evaluation of Patients with Unresectable Locally Advanced or Locally Recurrent Head and Neck Carcinoma Treated with Head and Neck Photoimmunotherapy
Isaku Okamoto et al.
CANCERS (2022)
A Case Treated With Photoimmunotherapy Under a Navigation System for Recurrent Lesions of the Lateral Pterygoid Muscle
Isaku Okamoto et al.
IN VIVO (2022)
Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Reprinted from Annals of Oncology, vol 31, pg 1462, 2020)
J. -P. Machiels et al.
ORAL ONCOLOGY (2021)
Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma
David M. Cognetti et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma
Makoto Tahara et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy
Takuya Kato et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors
Yasuhiro Maruoka et al.
CANCERS (2020)
Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)
Mohammad R. Siddiqui et al.
SCIENTIFIC REPORTS (2019)
The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy
Ryuhei Okada et al.
BIOCONJUGATE CHEMISTRY (2019)
Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort
Iain L. Hutchison et al.
BRITISH JOURNAL OF CANCER (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
Ezra E. W. Cohen et al.
LANCET (2019)
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
Hisham Mehanna et al.
LANCET (2019)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison et al.
LANCET (2019)
Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinoma
Nicholas C. J. Lee et al.
ORAL ONCOLOGY (2018)
Photoinduced Ligand Release from a Silicon Phthalocyanine Dye Conjugated with Monoclonal Antibodies: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy
Kazuhide Sato et al.
ACS CENTRAL SCIENCE (2018)
Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancer
Yanqun Dong et al.
ORAL ONCOLOGY (2017)
Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity
Mikako Ogawa et al.
ONCOTARGET (2017)
Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques
Jonathan E. Leeman et al.
JAMA ONCOLOGY (2017)
Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms
Kimihiro Ito et al.
BMC CANCER (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific Antibodies
Hua Jing et al.
THERANOSTICS (2016)
Prevalence of Human Papillomavirus in Oropharyngeal Cancer A Systematic Review
Andrew P. Stein et al.
CANCER JOURNAL (2015)
Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Assuntina G. Sacco et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxel
Hirofumi Hanaoka et al.
NANOMEDICINE (2015)
Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer
Anil K. D'Cruz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Oncologic Outcomes After Transoral Robotic Surgery A Multi-institutional Study
John R. de Almeida et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2015)
Near Infra-Red Photoimmunotherapy with Anti-CEA-IR700 Results in Extensive Tumor Lysis and a Significant Decrease in Tumor Burden in Orthotopic Mouse Models of Pancreatic Cancer
Ali A. Maawy et al.
PLOS ONE (2015)
Salvage Surgery for Recurrent Cancers of the Oropharynx Comparing TORS With Standard Open Surgical Approaches
Hilliary White et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2013)
Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
Makoto Mitsunaga et al.
NATURE MEDICINE (2011)
Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis
Mitchell Machtay et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer
J Mendelsohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
